Bio-Rad Laboratories | BIO - Ebitda


Bio-Rad Laboratories reported $-636.6M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 456M 84M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD -636.6M 1.62B Mar/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Danaher USD 1.84B 81M Jun/2026
General Electric Aerospace USD 3.06B 219M Jun/2026
Illumina USD 330M 80M Jun/2026
IQVIA Holdings USD 994M 62M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Merck USD -1.54B 7.84B Mar/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quest Diagnostics USD 648M 91M Jun/2026
Repligen USD 43.77M 3.76M Jun/2026
Revvity USD 228.18M 44.73M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Siemens EUR 3.56B 80M Mar/2026
Standard Biotools USD -8.01M 7.8M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Tosoh JPY 39.13B 286M Dec/2024
Waters USD 712M 545M Jun/2026